RP103 (cysteamine bitartrate delayed-release capsules)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RP103 (cysteamine bitartrate delayed-release capsules), covering 2017-05-24 to 2018-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis [Phase 3]